BATS — British American Tobacco Balance Sheet
0.000.00%
- £96.45bn
- £127.07bn
- £25.87bn
- 50
- 37
- 99
- 70
Annual balance sheet for British American Tobacco, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,381 | 3,265 | 4,025 | 5,260 | 5,810 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,800 | 4,068 | 4,516 | 3,793 | 3,671 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13,612 | 12,807 | 15,409 | 14,186 | 14,294 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,060 | 4,953 | 4,867 | 4,583 | 4,379 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 137,690 | 137,365 | 153,546 | 118,716 | 118,899 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15,478 | 15,144 | 17,853 | 15,673 | 18,743 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 75,017 | 70,264 | 78,178 | 66,150 | 69,256 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 62,673 | 67,101 | 75,368 | 52,566 | 49,643 |
| Total Liabilities & Shareholders' Equity | 137,690 | 137,365 | 153,546 | 118,716 | 118,899 |
| Total Common Shares Outstanding |